AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IONIS PHARMACEUTICALS INC Director's Dealing 2013

Aug 28, 2013

30591_dirs_2013-08-28_eee89083-77cd-43eb-8754-f7f40f8adc74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2013-08-28

Reporting Person: Monia Brett P (SVP, Antisense Drug Discovery)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2909	Direct

Footnotes

F1: The original number of non-derivative securities beneficially owned were inadvertently overstated on the reporting person's original Form 3, and also were inadvertently overstated on eleven Forms 4 filed by the reporting person after his original Form 3 was filed.